Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Henkel AG and Co KGaA | 169 |
| 2 | Fujifilm Holdings Corp | 49 |
| 3 | BASF SE | 39 |
| 4 | Memorial Sloan Kettering Cancer Center | 16 |
| 5 | Yale University | 13 |
| 6 | Takeda Pharmaceutical Co Ltd | 11 |
| 7 | Bayer AG | 10 |
| 8 | Sumitomo Chemical Co Ltd | 10 |
| 9 | The University of Texas System | 10 |
| 10 | Institut National de la Santé et de la Recherche Médicale | 9 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 561 |
| 2 | A61P | Therapeutic activity (drug indications) | 420 |
| 3 | C07D | Heterocyclic compounds | 297 |
| 4 | A61Q | Cosmetics, personal care | 218 |
| 5 | C07K | Peptides | 103 |
| 6 | G01N | Investigating / analysing materials | 85 |
| 7 | C09B | 80 | |
| 8 | C12N | Microorganisms, enzymes | 77 |
| 9 | C07C | Acyclic and carbocyclic compounds | 54 |
| 10 | G03C | 32 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Improved 6-nitro-1-diazo-2-naphthol-4-sulphonic acid production process | 2016 | 9 | |
| Method for performing Fenton treatment on 6-nitro-1-diazo-2-naphthol-4-sulfonic acid wastewater and coproducing sodium sulfate | 2016 | 5 | |
| Method and equipment for continuously producing 6-nitro-1, 2, 4-acid oxygen | 2022 | 1 | |
| Method for preparing 6-nitro-1, 2-diazoxynaphthalene-4-sulfonic acid | 2015 | 1 | |
| Preparation method of 6-nitro-1, 2, 3, 3-tetramethyl benzpyrole | 2016 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 9 |
| 2017 | 12 |
| 2018 | 11 |
| 2019 | 17 |
| 2020 | 21 |
| 2021 | 9 |
| 2022 | 14 |
| 2023 | 15 |
| 2024 | 14 |
| 2025 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Patricia Dranchak | National Center for Advancing Translational Sciences | 4 |
| 2 | Jamal Mohammadian | Tabriz University of Medical Sciences | 3 |
| 3 | Jiayuh Lin | The Ohio State University | 3 |
| 4 | Pui‐Kai Li | The Ohio State University | 3 |
| 5 | Mehdi Sabzichi | University of Alberta | 3 |
| 6 | Rainer Schulz | Justus-Liebig-Universität Gießen | 2 |
| 7 | Adam Yasgar | National Institutes of Health | 2 |
| 8 | Serge Goupil | Université Laval | 2 |
| 9 | Sander Busker | Karolinska Institutet | 2 |
| 10 | Afsaneh Lavasanifar | University of Alberta | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Stattic: A Small-Molecule Inhibitor of STAT3 Activation and Dimerization | 2006 | 1121 | PI3K/AKT/mTOR signaling in cancer |
| Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis | 2016 | 378 | Osteoarthritis Treatment and Mechanisms |
| STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells | 2011 | 308 | Cancer Cells and Metastasis |
| Mitochondrial STAT3 Activation and Cardioprotection by Ischemic Postconditioning in Pigs With Regional Myocardial Ischemia/Reperfusion | 2011 | 303 | Organ Transplantation Techniques and Outcomes |
| STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria | 2009 | 263 | Immune Response and Inflammation |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and structure of Stattic?
What is the primary research application of Stattic based on published literature?
Which organizations hold the most patents involving Stattic?
How has patent activity around Stattic evolved in recent years?
What are the primary CPC technology classifications associated with Stattic patents?